Jackson Square Capital, LLC Novo Nordisk A S Transaction History

Jackson Square Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 05, 2021	SELL	$63.89 - $73.8 $11,564 - $13,357	-181 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$63.69 - $70.22 $38,596 - $42,553	-606 Reduced 77.0%	181 $13,000
Q2 2020 Aug 18, 2020	SELL	$58.54 - $67.94 $3,863 - $4,484	-66 Reduced 7.74%	787 $52,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $12,315 - $16,130	249 Added 41.23%	853 $51,000
Q4 2019 May 15, 2020	BUY	$49.86 - $58.26 $30,115 - $35,189	604 New	604 $35,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.